Is hnge a buy sell or hold

**Hinge Health (HNGE) appears to be a strong buy** based on the following points:

1. **Positive Analyst Ratings and Price Targets**: The consensus rating for HNGE is "Buy" with 15 analysts giving a buy recommendation and one giving a strong buy recommendation. The average target price is $53.07, which is higher than the current trading price.
2. **Strong Revenue Growth and Profitability**: Hinge Health reported a 52% year-over-year revenue growth in Q2 2025, reaching $139.1 million, surpassing market expectations. The company also reported a non-GAAP operating income of $26.1 million in Q2 2025, indicating improved efficiency.
3. **Strategic Acquisitions and Partnerships**: The company's acquisition of a major European competitor signals a significant growth opportunity. Additionally, strategic partnerships with wearable tech and AI-powered solutions are expected to revolutionize service offerings and increase revenue streams.
4. **Momentum and Market Position**: Hinge Health's stock has shown strong momentum, surging 20.8% following the announcement of its acquisition and upbeat quarterly earnings. The company is positioned as a potential market leader in digital health solutions and is effectively expanding its foothold in both North American and European markets.
5. **Financial Health and Long-Term Potential**: Hinge Health's robust revenue growth, solid gross margin, and strategic moves position it well for long-term success. The company's pivot to smartphone-based care is seen as a masterstroke in scalability.

In conclusion, the combination of positive analyst ratings, strong financial performance, strategic initiatives, and market momentum suggest that Hinge Health is a compelling buy. Investors should consider the high growth potential and the company's strategic positioning in the digital health sector.